Increased cell-mediated immune responses in patients with recurrent herpes simplex virus type 2 meningitis

Clinical and Vaccine Immunology

Volumn 18, Issue 4, 2011, Pages 655-660

  Franzen Röhl, Elisabeth ^a   Schepis, Danika ^b   Lagrelius, Maria ^a   Franck, Kristina ^c   Jones, Petra ^c   Liljeqvist, Jan Åke ^d   Bergström, Tomas ^d   Aurelius, Elisabeth ^a   Kärre, Klas ^b   Berg, Louise ^b   Gaines, Hans ^a,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 9; VIRUS ANTIGEN;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; GENITAL HERPES; HERPES SIMPLEX 2 ENCEPHALITIS; HERPES SIMPLEX ENCEPHALITIS; HUMAN; HUMAN CELL; INNATE IMMUNITY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT INFECTION; REMISSION; T LYMPHOCYTE;

ADULT; CYTOKINES; DENDRITIC CELLS; FEMALE; GENE EXPRESSION; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; MALE; MENINGITIS, VIRAL; MIDDLE AGED; RECURRENCE; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS;

EID: 79954456304     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00333-10     Document Type: Article

References (52)

1. Afonso, N., et al. 2007. Appropriate use of polymerase chain reaction for detection of herpes simplex virus 2 in cerebrospinal fluid of patients at an inner-city hospital. Diagn. Microbiol. Infect. Dis. 57:309-313.
2. Aurelius, E. 2006. Neurological disease in herpes simplex virus type 2 infection, p. 317-338. In M. Studahl, P. Cinque, and T. Bergström (ed.), Herpes simplex viruses. Taylor and Francis Group, New York, NY.
3. Aurelius, E., M. Forsgren, E. Gille, and B. Skoldenberg. 2002. Neurologic morbidity after herpes simplex virus type 2 meningitis: a retrospective study of 40 patients. Scand. J. Infect. Dis. 34:278-283.
4. Aurelius, E., B. Johansson, B. Skoldenberg, and M. Forsgren. 1993. Encephalitis in immunocompetent patients due to herpes simplex virus type 1 or 2 as determined by type-specific polymerase chain reaction and antibody assays of cerebrospinal fluid. J. Med. Virol. 39:179-186.
5. Aurelius, E., B. Johansson, B. Skoldenberg, A. Staland, and M. Forsgren. 1991. Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid. Lancet 337:189-192.
6. Bergstrom, T., et al. 1990. Primary and recurrent herpes simplex virus type 2-induced meningitis. J. Infect. Dis. 162:322-330.
7. Casrouge, A., et al. 2006. Herpes simplex virus encephalitis in human UNC- 93B deficiency. Science 314:308-312. (Pubitemid 44571977)
8. Corey, L., H. G. Adams, Z. A. Brown, and K. K. Holmes. 1983. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann. Intern. Med. 98:958-972.
9. Dupuis, S., et al. 2003. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33:388-391.
10. Franzen-Rohl, E., et al. 2008. High diagnostic yield by CSF-PCR for enteroand herpes simplex viruses and TBEV serology in adults with acute aseptic meningitis in Stockholm. Scand. J. Infect. Dis. 40:914-921.
11. Franzen-Rohl, E., A. Tiveljung-Lindell, L. Grillner, and E. Aurelius. 2007. Increased detection rate in diagnosis of herpes simplex virus type 2 meningitis by real-time PCR using cerebrospinal fluid samples. J. Clin. Microbiol. 45:2516-2520.
12. Heller, F., et al. 2005. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129:550-564. (Pubitemid 41096643)
13. Hochrein, H., et al. 2004. Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. Proc. Natl. Acad. Sci. U. S. A. 101:11416-11421.
14. + T cells. J. Virol. 81:8157-8164.
15. Johnston, C., et al. 2008. Herpes simplex virus viremia during primary genital infection. J. Infect. Dis. 198:31-34.
16. Jonsson, M. K., M. Levi, U. Ruden, and B. Wahren. 2006. Minimal change in HSV-2 seroreactivity: a cross-sectional Swedish population study. Scand. J. Infect. Dis. 38:357-365.
17. Kallio-Laine, K., et al. 2009. Recurrent lymphocytic meningitis positive for herpes simplex virus type 2. Emerg. Infect. Dis. 15:1119-1122.
18. Kim, J. V., S. S. Kang, M. L. Dustin, and D. B. McGavern. 2009. Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature 457:191-195.
19. Knickelbein, J. E., et al. 2008. Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science 322:268-271.
20. Koelle, D. M., H. Abbo, A. Peck, K. Ziegweid, and L. Corey. 1994. Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions. J. Infect. Dis. 169:956-961.
21. + T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions. J. Virol. 68:2803-2810.
22. Kupila, L., R. Vainionpaa, T. Vuorinen, R. J. Marttila, and P. Kotilainen. 2004. Recurrent lymphocytic meningitis: the role of herpesviruses. Arch. Neurol. 61:1553-1557.
23. Langenberg, A. G., L. Corey, R. L. Ashley, W. P. Leong, and S. E. Straus. 1999. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N. Engl. J. Med. 341:1432-1438.
24. Lester, R. T., et al. 2008. Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection. AIDS 22:685-694. (Pubitemid 351450636)
25. Liu, T., K. M. Khanna, X. Chen, D. J. Fink, and R. L. Hendricks. 2000. CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J. Exp. Med. 191:1459-1466.
26. Lun, S. W., C. K. Wong, F. W. Ko, D. S. Hui, and C. W. Lam. 2009. Expression and functional analysis of Toll-like receptors of peripheral blood cells in asthmatic patients: implication for immunopathological mechanism in asthma. J. Clin. Immunol. 29:330-342.
27. Mark, K. E., et al. 2008. Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. J. Infect. Dis. 198:1141-1149.
28. Meier, A., et al. 2009. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat. Med. 15:955-959.
29. Mikloska, Z., and A. L. Cunningham. 1998. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes. J. Gen. Virol. 79(pt. 2):353-361.
30. Mollaret, P. 1944. La meningite endothelio-leucocytaire multirecurrente benigne. Syndrome nouveau ou maladie nouvelle. Documents clinique. Rev. Neurol. Paris 76:57-76.
31. Orange, J. S., and Z. K. Ballas. 2006. Natural killer cells in human health and disease. Clin. Immunol. 118:1-10.
32. Pebody, R. G., et al. 2004. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex. Transm. Infect. 80:185-191.
33. Peri, P., et al. 2008. Herpes simplex virus type 1 Us3 gene deletion influences Toll-like receptor responses in cultured monocytic cells. Virol. J. 5:140.
34. Posavad, C. M., M. Remington, D. E. Mueller, L. Zhao, A. S. Magaret, A. Wald, and L. Corey. 2010. Detailed characterization of T cell responses to herpes simplex virus-2 in immune seronegative persons. J. Immunol. 184:3250-3259.
35. Ramaswamy, M., and A. M. Geretti. 2007. Interactions and management issues in HSV and HIV coinfection. Expert Rev. Anti Infect. Ther. 5:231-243.
36. Schlesinger, Y., P. Tebas, M. Gaudreault-Keener, R. S. Buller, and G. A. Storch. 1995. Herpes simplex virus type 2 meningitis in the absence of genital lesions: improved recognition with use of the polymerase chain reaction. Clin. Infect. Dis. 20:842-848.
37. Skoldenberg, B., S. Jeansson, and S. Wolontis. 1975. Herpes simplex virus type 2 and acute aseptic meningitis. Clinical features of cases with isolation of herpes simplex virus from cerebrospinal fluids. Scand. J. Infect. Dis. 7:227-232.
38. Sun, J. C., J. N. Beilke, and L. L. Lanier. 2009. Adaptive immune features of natural killer cells. Nature 457:557-561.
39. Sundqvist, V. A., A. Linde, and B. Wahren. 1984. Virus-specific immunoglobulin G subclasses in herpes simplex and varicella-zoster virus infections. J. Clin. Microbiol. 20:94-98.
40. Svahn, A., et al. 2003. Development and evaluation of a flow-cytometric assay of specific cell-mediated immune response in activated whole blood for the detection of cell-mediated immunity against varicella-zoster virus. J. Immunol. Methods 277:17-25. (Pubitemid 36694370)
41. Tabeta, K., et al. 2004. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. U. S. A. 101:3516-3521.
42. Tabeta, K., et al. 2006. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat. Immunol. 7:156-164.
43. Tedder, D. G., R. Ashley, K. L. Tyler, and M. J. Levin. 1994. Herpes simplex virus infection as a cause of benign recurrent lymphocytic meningitis. Ann. Intern. Med. 121:334-338.
44. Theil, D., et al. 2003. Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am. J. Pathol. 163:2179-2184.
45. Tilton, J. C., et al. 2008. Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro. J. Virol. 82:3997-4006. (Pubitemid 351521235)
46. Verjans, G. M., et al. 2007. Selective retention of herpes simplex virusspecific T cells in latently infected human trigeminal ganglia. Proc. Natl. Acad. Sci. U. S. A. 104:3496-3501.
47. Wald, A., J. Zeh, S. Selke, R. L. Ashley, and L. Corey. 1995. Virologic characteristics of subclinical and symptomatic genital herpes infections. N. Engl. J. Med. 333:770-775.
48. Xu, F., et al. 2002. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. J. Infect. Dis. 185:1019-1024.
49. Xu, F., et al. 2006. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296:964-973. (Pubitemid 44285373)
50. Zhang, S. Y., et al. 2007. Human Toll-like receptor-dependent induction of interferons in protective immunity to viruses. Immunol. Rev. 220:225-236.
51. Zhang, S. Y., et al. 2007. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:1522-1527.
52. Zhu, J., et al. 2007. Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation. J. Exp. Med. 204:595-603.